Cancer Patients Pay for Evidence-Based Integrative Care — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Society for Integrative Oncology (SIO) and American Society of Clinical Oncology (ASCO) have jointly developed clinical practice guidelines for integrative oncology, with further recommendations embedded throughout National Comprehensive Cancer Network (NCCN) symptom management pathways.
- Acupuncture, mindfulness-based interventions, and exercise and nutrition counseling are recommended by these guidelines for cancer-related pain, nausea, anxiety, depression, fatigue, sleep disturbance, and neuropathy — yet insurance coverage remains inconsistent and varies by patient geography and insurer.
- Lorenzo Cohen's preclinical research published in Cancer Medicine found that standardized biofield therapy inhibited pancreatic cancer cell growth and invasiveness in vitro, reduced liver metastasis in mouse models, and produced changes in FOXM1, mitochondrial structure, cell cycle regulation, and membrane voltage potential.
- The Department of Veterans Affairs includes reiki, healing touch, and therapeutic touch among its integrative health offerings, and major U.S. hospitals are quietly integrating biofield approaches into routine supportive care delivered by trained nurses.
- Medicare, Medicaid, and private insurers should update coverage policies to mirror NCCN and SIO-ASCO recommendations, Cohen argues, noting insurers routinely cover extraordinarily expensive drugs with modest benefit while excluding lower-cost integrative therapies.
- Coverage gaps persist because insurers still view integrative therapies as optional, and because benefits like avoided hospitalizations, better treatment adherence, and improved symptom control are less visible than the upfront cost of the service.
Why it matters: Cancer patients in the U.S. currently pay out of pocket for treatments that ASCO, NCCN, and the VA have endorsed — acupuncture, mindfulness programs, exercise counseling, biofield therapies — creating a system where two patients with identical diagnoses receive different supportive care based on geography and insurer rather than medical need. Cohen's pancreatic cancer preclinical findings on biofield therapy also signal an emerging research front where coverage policy has not yet caught up with the underlying biology.
Ask SkimNews
